NEWS
LifePoint, Inc. Invites You to Join its Third Quarter Fiscal 2003 Conference Call
10 Feb 2003, 11:15am ET
E-mail or Print this story
- - - - -
ONTARIO, Calif.--(BUSINESS WIRE)--Feb. 10, 2003--LifePoint, Inc.
(AMEX:LFP), announced that in conjunction with the Company's fiscal
2003 third quarter earnings release, you are invited to listen to its
conference call on Friday, February 14, 2003 at 9:00 a.m., EST (6:00
a.m. PST), with Linda H. Masterson, President and CEO and Michele
Clark, Controller and Chief Accounting Officer.
What: LifePoint, Inc.'s Fiscal 2003 Third Quarter Conference Call
When: Friday, February 14, 2003, 9:00 a.m. EST
Web address: www.streetevents.com, www.companyboardroom.com, or
www.LifePointInc.com
Dial-in numbers: 1-800-915-4836 (domestic) and 1-973-317-5319
(international)
Contact: Lester Rosenkrantz, Cameron Associates, 212-245-8800 x212
If you are unable to participate, an audio digital replay of the
call will be available from Friday, February 14th at 11 a.m. EST until
Midnight EST on February 21st by dialing 1-800-428-6051 (domestic) or
973-709-2089 (international) using confirmation code #286161. A web
archive will be available for 30 days at www.streetevents.com,
www.companyboardroom.com , or www.LifePointInc.com. The company will
issue its quarterly letter to shareholders following the conference
call.
About LifePoint, Inc.
LifePoint, Inc., a leader in non-invasive drug diagnostic
technologies and solutions, has developed, manufactures and markets
the IMPACT Test System - a rapid diagnostic testing, screening and
drug monitoring device for use in the workplace, home health care,
ambulances, pharmacies and law enforcement. LifePoint's patented and
proprietary technologies for the use of saliva as a non-invasive,
blood-comparable test specimen, used in conjunction with the flow
immunosensor technology licensed from the United States Navy, has
allowed LifePoint to develop a broadly applicable, rapid, on-site
diagnostic test system. The first product simultaneously detects drugs
of abuse and alcohol, with the initial three target markets estimated
to be over $1.6 billion.
LifePoint(R) and IMPACT(R) are trademarks of LifePoint, Inc.
CONTACT: LifePoint, Inc.
Linda H. Masterson, 909/418-3000 x 400
e-mail: LifePoint@LFPT.com
Web site: www.LifePointInc.com
or
Cameron Associates
Lester Rosenkrantz, 212/245-8800 ext. 212
e-mail: lester@cameronassoc.com
KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: MEDICAL DEVICES ADVISORY CONFERENCE CALLS
SOURCE: LifePoint, Inc.